Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nagase, Satoru
NCT04063527: Phase III Trial of Stage I Ovarian Cancer After Surgery	Recruiting	3	360	Japan, RoW	adjuvant chemotherapy, paclitaxel and carboplatin	Japanese Gynecologic Oncology Group, Korean Gynecologic Oncology Group	Epithelial Ovarian Cancer	10/29	02/30
NIRVANA-1, NCT05183984 / 2021-004278-76: Niraparib with BeVAcizumab After Complete CytoreductioN in Patients with OvArian Cancer	Recruiting	2	390	Europe, Japan, RoW	Chemotherapy, Bevacizumab-Awwb, Niraparib	ARCAGY/ GINECO GROUP, GSK	Ovarian Cancer	02/27	02/30